BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35071745)

  • 1. DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas.
    Zhu X; Perales-Puchalt A; Wojtak K; Xu Z; Yun K; Bhojnagarwala PS; Bordoloi D; Park DH; Liaw K; Bah MA; Lieberman PM; Gary EN; Patel A; Weiner DB
    Mol Ther Oncolytics; 2022 Mar; 24():218-229. PubMed ID: 35071745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique variations of Epstein-Barr virus-encoded BARF1 gene in nasopharyngeal carcinoma biopsies.
    Wang Y; Wang XF; Sun ZF; Luo B
    Virus Res; 2012 Jun; 166(1-2):23-30. PubMed ID: 22406129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy.
    Kalra M; Gerdemann U; Luu JD; Ngo MC; Leen AM; Louis CU; Rooney CM; Gottschalk S
    Cytotherapy; 2019 Feb; 21(2):212-223. PubMed ID: 30396848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Therapeutic Potential of Targeting BARF1 in EBV-Associated Malignancies.
    Lo AK; Dawson CW; Lung HL; Wong KL; Young LS
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Methylation Status and Expression of Epstein-Barr Virus Early Genes BARF1 and BHRF1 in Epstein-Barr Virus-Associated Gastric Carcinomas.
    Li J; Liu W; Che K; Zhang Y; Zhao Z; Luo B
    Gastroenterol Res Pract; 2017; 2017():3804146. PubMed ID: 28487730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous T cell responses to Epstein-Barr virus-encoded BARF1 protein and derived peptides in patients with nasopharyngeal carcinoma: bases for improved immunotherapy.
    Martorelli D; Houali K; Caggiari L; Vaccher E; Barzan L; Franchin G; Gloghini A; Pavan A; Da Ponte A; Tedeschi RM; De Re V; Carbone A; Ooka T; De Paoli P; Dolcetti R
    Int J Cancer; 2008 Sep; 123(5):1100-7. PubMed ID: 18546263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of BamHI-A Rightward Frame 1 in Epstein-Barr Virus-Associated Epithelial Malignancies.
    Blanco R; Aguayo F
    Biology (Basel); 2020 Dec; 9(12):. PubMed ID: 33322292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression.
    Seto E; Yang L; Middeldorp J; Sheen TS; Chen JY; Fukayama M; Eizuru Y; Ooka T; Takada K
    J Med Virol; 2005 May; 76(1):82-8. PubMed ID: 15778977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma.
    Hutajulu SH; Hoebe EK; Verkuijlen SA; Fachiroh J; Hariwijanto B; Haryana SM; Stevens SJ; Greijer AE; Middeldorp JM
    Infect Agent Cancer; 2010 Sep; 5():16. PubMed ID: 20849661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purified hexameric Epstein-Barr virus-encoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients.
    Hoebe EK; Hutajulu SH; van Beek J; Stevens SJ; Paramita DK; Greijer AE; Middeldorp JM
    Clin Vaccine Immunol; 2011 Feb; 18(2):298-304. PubMed ID: 21123521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody and antibody-dependent cellular cytotoxicity responses against the BamHI A rightward open-reading frame-1 protein of Epstein-Barr virus (EBV) in EBV-associated disorders.
    Tanner JE; Wei MX; Alfieri C; Ahmad A; Taylor P; Ooka T; Menezes J
    J Infect Dis; 1997 Jan; 175(1):38-46. PubMed ID: 8985194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors.
    Turrini R; Merlo A; Martorelli D; Faè DA; Sommaggio R; Montagner IM; Barbieri V; Marin O; Zanovello P; Dolcetti R; Rosato A
    Oncoimmunology; 2017; 6(4):e1304338. PubMed ID: 28507812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr Virus Gene BARF1 Expression is Regulated by the Epithelial Differentiation Factor ΔNp63α in Undifferentiated Nasopharyngeal Carcinoma.
    Hoebe E; Wille C; Hagemeier S; Kenney S; Greijer A; Middeldorp J
    Cancers (Basel); 2018 Mar; 10(3):. PubMed ID: 29562599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence variations of Epstein-Barr virus-encoded BARF1 gene in nasopharyngeal carcinomas and healthy donors from southern and northern China.
    Liu J; Ji X; Shen Z; Wang PhD Y; Luo PhD B
    J Med Virol; 2018 Oct; 90(10):1629-1635. PubMed ID: 29797589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
    Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
    Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence analysis of Epstein-Barr virus (EBV) early genes BARF1 and BHRF1 in NK/T cell lymphoma from Northern China.
    Sun L; Che K; Zhao Z; Liu S; Xing X; Luo B
    Virol J; 2015 Sep; 12():135. PubMed ID: 26337172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene.
    zur Hausen A; Brink AA; Craanen ME; Middeldorp JM; Meijer CJ; van den Brule AJ
    Cancer Res; 2000 May; 60(10):2745-8. PubMed ID: 10825150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of Epstein-Barr virus and its encoded proteins with Helicobacter pylori and expression of c-met and c-myc in gastric carcinoma.
    Luo B; Wang Y; Wang XF; Gao Y; Huang BH; Zhao P
    World J Gastroenterol; 2006 Mar; 12(12):1842-8. PubMed ID: 16609989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broadening Specificity and Enhancing Cytotoxicity of Adoptive T Cells for Nasopharyngeal Carcinoma Immunotherapy.
    Faè DA; Martorelli D; Mastorci K; Muraro E; Dal Col J; Franchin G; Barzan L; Comaro E; Vaccher E; Rosato A; Dolcetti R
    Cancer Immunol Res; 2016 May; 4(5):431-40. PubMed ID: 27009165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity.
    Seto E; Ooka T; Middeldorp J; Takada K
    Cancer Res; 2008 Feb; 68(4):1030-6. PubMed ID: 18281477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.